CTRI/2022/01/039737
Completed
Phase 3
An Open-Label Clinical Trial To Evaluate The Anti-dandruff Effect of Darunagna Lepa Converted Into Lotion
Dr Aiswarya Mohan0 sites30 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr Aiswarya Mohan
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients having Adherent Scalp Flaking Score (ASFS) score \>24\.
- •Patients having classical features of darunaka i.e Kandu (Itching) , Kesha bhoomi
- •rookshata (Dryness of scalp) , Kesha chyuti (Hair fall) and Kesha bhoomi prapatana (Flaking).
Exclusion Criteria
- •Diagnosed cases of Psoriasis, Alopecia
- •Ã¢â?¬Â¢ Pregnancy, Lactating women
- •Ã¢â?¬Â¢ Patients under systemic or topical antibiotics, steroids, immunomodulating drugs, and
- •undergone hair growth treatments.
- •Ã¢â?¬Â¢ History of allergic reaction to topically applied hair care products.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 2
Clinical evaluation for the efficacy of Muliv strong syrup in the management of Non- Alcoholic Fatty Liver disease (NAFLD).CTRI/2019/12/022578Multani Pharmaceuticals Ltd
Not yet recruiting
Phase 2
Clinical Trial for Diabetic Foot Ulcer through Siddha medicinesHealth Condition 1: E116- Type 2 diabetes mellitus with other specified complicationsCTRI/2023/10/058661ational Institute of Siddha
Completed
Phase 2
Management of Hair Fall through Rovaan Poshaka TailaHealth Condition 1: L639- Alopecia areata, unspecifiedCTRI/2020/01/022718Multani Pharmaceuticals Ltd50
Not yet recruiting
Not Applicable
To evaluate the efficacy of medicated enema therapy and external oleation therapy followed by oral medication in the management of hip joint pain.CTRI/2024/07/070233ational Institute of Ayurveda
Unknown
Phase 2
Management Madhumeha (Diabetes mellitus type 2)CTRI/2020/01/022662Multani Pharmaceuticals Ltd